Oral liquid for relieving male climacteric syndrome and preparation method of oral liquid

Abstract

The invention discloses an oral liquid for relieving male climacteric syndrome and a preparation method of the oral liquid. The oral liquid comprises the following drug substances in parts by weight: 3-15 parts of maca, 5-30 parts of epimedium, 7-30 parts of semen cuscutae, 1-5 parts of herba cynomorii, 1-5 parts of cortex eucommiae, 1-5 parts of bulbus lilii, 6-30 parts of fructus lycii, 1-5 parts of L-arabinose, 5-10 parts of valerian root, 5-10 parts of pigeonpea, 5-8 parts of rhizoma acori graminei, 3-9 parts of radix curcumae, 10-15 parts of rhizoma polygonati, 8-15 parts of spina date seeds and 15-20 parts of flos albiziae. Starting from the pathogenesis of male climacteric syndrome, various components are reasonably matched to effectively relieve and improve male climacteric syndrome, and the oral liquid has no toxic or side effects and relieves aging degradation of organs without influencing own hormone secretion. The oral liquid can not only treat but also prevent male climacteric syndrome.

Description

technical field [0001] The invention relates to the field of traditional Chinese medicine, in particular to an oral liquid capable of alleviating male climacteric syndrome and a preparation method thereof. Background technique [0002] Andropause syndrome refers to a specific age stage in which men transition from middle age to old age. It generally occurs in the age group of 45-55 years old, and can also be as early as 35 years old or delayed to 65 years old. Andropause is caused by the degeneration of testicular function. Foreign studies report that about 40% of middle-aged and elderly men may experience different degrees of menopausal symptoms. It is a transitional period based on the transition of male hormone levels and psychological states from prosperity to decline. . The clinical symptoms mainly include: (1) Mental symptoms: mainly temperament changes, such as depression, sadness, depression, want to cry, nervousness, nervousness, moodiness, cranky, suspicious, lack...

AI Technical Summary

Problems solved by technology

[0004] It can be seen from the above that although both are menopausal syndromes, the pathogenesis and symptoms of female menopausal syndrome and male menopausal syndrome are different, so the direction of medication is different

[0005] In my country, andropause education has just started, and the public's awareness of andropause is relatively low. The drug currently used to treat andropause syndrome is generally methyltestosterone. Hormones decrease, which eventually leads to testicular atrophy, insufficient male hormone secretion and other side effects. However, most of the health care products on the market that can relieve menopausal syndrome are women's products, and there are few effective men's products.